Researchers study how existing health conditions relate to complications after abdominal surgery.
Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓
This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.
These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.
Full study name & original research details
Official study title
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification - a Prospective Observational Multi-center Cohort Study
Short title used by the registry
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Original description
Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.
Further description from the registry
Advances in modern anesthesiology have significantly reduced the risk of anesthesia compared to the last century, however, the level of perioperative hospital mortality of planned operations at the moment is on average about 0.5% (ISOS group, 2016). Weiser et al. (2016) estimated that more than 313 million adults worldwide are subject to surgery each year. Thus, the number of deaths may result in several million each year worldwide. However, the study of the mortality risk is associated with certain difficulties, because over the past half century, this figure has decreased a hundred times and the study requires studies that include a large number of participants.
Current research focuses on other outcome criteria - postoperative complications. Thus, anesthetic risk often refers to the risk of postoperative complications. The frequency of these complications varies in a wide range, ranging from 3 to 18 % (Gawande AA, 1999, Kable AK, 2002, Malik OS, 2018). The differences in the data are explained by the lack of clear definitions and differences in the design of studies, but the fact that the development of postoperative complications increases the risk of death several times (ISOS group, 2016) can be considered undoubted. However, despite the importance of this issue, in modern literature there is no clear idea of what is considered a high risk and which of the patients corresponds to this category.
Understanding whether a patient is at high risk is an essential task - it allows you to obtain meaningful informed consent of the patient, as well as to understand whether to apply strategies for the prevention of complications (targeted infusion therapy, protective respiratory support, especially monitoring in the postoperative period, etc.).
Attempts at preoperative risk stratification have been made for many decades, some scales estimate the initial physical status (ASA scale) (Young J, 2015) and predict mortality, others estimate the risk of specific complications (Lee index, respiratory risk scale, etc.) .
Scales including intraoperative and postoperative parameters such as the POSSUM series of scales (Whiteley MS, 1996) are also being developed. The analysis shows that in routine clinical practice, these scales are not used very often, due to their limitations: subjectivity, technical complexity and often - low specificity and sensitivity.
Concomitant diseases are the strongest predictors of postoperative adverse events and annual mortality. Monk et al. (2005) demonstrated that Charlson's comorbidity score of 3 or more significantly increased the risk of death. In addition, in most clinical studies, the ASAclassification of physical status as a kind of comprehensive assessment of patient comorbidity has repeatedly proved to be one of the strongest independent predictors of postoperative morbidity and mortality, despite the fact that this assessment is based on subjective perception (Watt J., 2018).
The main concomitant diseases that are independent predictors of perioperative complications are diseases of the cardiovascular and respiratory systems (Van Diepen S, 2011). Increasing age, anemia, obesity, diabetes - these conditions also increase the risk of an adverse outcome. Diseases of the Central nervous system and neuromuscular diseases significantly disrupt the function of respiration, can change the level of the Autonomous regulation of the cardiovascular system, lead to significant cognitive disorders and nutritional deficiency, which also increases the risk of perioperative complications (Hachenberg T, 2014).
On the other hand, large-scale observational studies conducted in recent years in a number of countries have not identified comorbidities as independent predictors of postoperative complications (Malik, 2018).
Thus, data on the risk effects of comorbidities are contradictory and may be influenced by differences in the frequency and structure of these diseases in heterogeneous populations, as well as in different treatment strategies for cardiovascular, respiratory and other diseases. The identification of these risk factors is necessary to understand the pathophysiology of complications and identify potential ways to reduce anesthetic risk, such as the correction of concomitant disease.
The degree of risk of surgery, of course, depends not only on the presence of comorbidities and their combinations, but also on the severity of surgical injury (Pearse RM, 2012, ISOS group, 2017), as well as the level of exposure to drugs for anesthesia and anesthetic techniques (Malik OS, 2018), therefore, the allocation of risk groups without these factors is also not appropriate.
Objective: to assess the frequency and structure of comorbidities in patients undergoing surgery on the abdominal organs and to stratify the risk of postoperative complications by determining independent
Evaluated parameters in study:
1\. Age, gender; 2. Class of physical status by ASA; 3. The presence and type of concomitant disease; 3.1 CHD; 3.2 CHF; 3.3 Heart rhythm disorders; 3.4 COPD; 3.5 Bronchial Asthma; 3.6 CKD; 3.7 CNS diseases; 3.7.1 Stroke; 3.7.2 Epilepsy; 3.7.3 Parkinson's Disease; 3.7.4 Alzheimer's Disease; 3.8 Neuromuscular diseases; 3.9 Diabetes; 3.10 Anemia; 4 Treatment received by the patient; 4.1 β-blockers; 4.2 ACE Inhibitors; 4.3 Aldosterone antagonists; 4.4 Statins; 4.5 Anticoagulants; 4.6 Diuretics; 4.7 Bronchodilators; 4.8 Corticosteriods; 4.9 Insulin; 4.10 Anticonvulsants; 5. The type and severity of surgery ; 5.1 Open surgery on the organs of the upper abdomen; 5.2 Coloproctological operations; 5.3 Gynecological surgery; 5.4 Urological surgery; 5.5 Operations on vessels of the abdominal cavity; 5.6 Abdominal wall surgery; 5.7 Laparoscopic surgery; 6 Type of anesthesia; 6.1 Spinal; 6.2 Epidural; 6.3 Combined spinal-epidural; 6.4 Intravenous; 6.5 Combined; 6.6 General+epidural; 7. Integral scales; 7.1 The cognitive function of the Montreal scale ; 7.2 Respiratory risk ; 7.3 Lee's Cardiovascular Risk Scale ; 7.4 NSQIP Cardiac risk scale ; 7.5 Hepatic insufficiency according to MELD; 7.6 CKD Stage by Level of GFR and Albuminuria; 7.7 COPD degree by GOLD.
Order of conduct
1. The data is registered in the Excel electronic database in a uniform format for all centers (the form will be sent by the coordinator to all centers participating in the study prior to the inclusion of patients).
2. All centers need to get approval by the local ethics committee before the start of the study. The study protocol will be registered in Clinicaltrial.gov.
3. The study includes all patients operated on within one operational day at the discretion of the center and meeting the inclusion criteria with registration in the questionnaire of the day of the week.
4. All patients could sign informed consent to participate in the study prior to inclusion in the study.
5. Before surgery, data on the patient and all studied factors specified in the study protocol are entered into the database.
6. All patients included in the study are monitored before discharge from the hospital with registration of the data specified in the protocol.
6\. Every last day of the working week, all completed cases are sent as a separate Excel file to the study coordinator by email to trembachnv@mail.ru 7. The originals of the questionnaires are stored in the centers for the entire study time and for 3 years after its completion.
8\. The summary database is formed by the study coordinator and provided to the centers after the end of the study.
Statistical analysis The sample size was calculated taking into account the fact that at least 10 cases of postoperative complications per one factor included in the final regression model are required. Given the wide range of complication rates in previous studies (from 3% to 20%), we have chosen a lower bound for a more accurate assessment. To include 20 potential risk factors in the regression model, 200 cases of postoperative complications are required, which at a frequency of 3% is not less than 7000 people. Taking into account the risk of data loss, and taking into account as many potential risk factors as possible, the size of the required sample was increased to 12,000 people, which will also assess the contribution of comorbidities to certain groups of complications. For validation of predictive models will be recruited 4,000 additional. The inclusion of the patient in the main and validation group will be carried out randomly.
The character of distribution of studied parameters will be evaluated using the criterion Kolmogorov-Smirnov. The continuous data will be presented as the median and interquartile range for the nonparametric distribution and as the mean and standard deviation for the parametric distribution. Categorical variables will be presented as the number of patients and a percentage of the total number of patients.
For the initial assessment of the Association of the factor with postoperative complications, a single-factor analysis using the χ2 criterion and the Mann-Whitney test will be carried out. All variables with a reliable relationship identified in the univariate analysis (p less than 0.05) will be included in logistic regression if there is no collinearity between them (correlation coefficient less than 0.25). The logistic regression model will be constructed using a step-by-step reverse inclusion procedure in which the presence of a complication will be a dependent variable. Potential predictors will be removed if this exception does not cause a significant change in the log likelihood ratio. The criterion for excluding the factor will be set at the significance level of 0.05. Adjusted odds ratios and 95% confidence intervals will also be calculated.
The resulting predictive model will be evaluated in the validation group using ROC analysis and the Hosmer-Lemeshov test.
Conditions reported: Coronary Heart Disease; Anemia; Bronchial Asthma; Stroke; Epilepsy; Parkinson's Disease; Heart Rhythm Disorders; Alzheimer's Disease; Neuromuscular Diseases; Diabetes; Chronic Heart Failure; Chronic Obstructive Pulmonary Disease; Chronic Kidney Diseases
Registry records for this study
Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.
- Study type
- Observational
- Interventions
- Not reported
- Phases
- Not reported
- Sponsor
- Russian Federation of Anesthesiologists and Reanimatologists
- Start date reported by registry
- 2019-07-01 (actual)
Registry updated: 2025-04-04 · Status last verified by the registry submitter: 2025-04
Registry records retrieved 2026-10-13 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.
Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.
Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.
The First City Clinical Hospital. n.a. E. E. Volosevich
Arkhangelsk, Russia
RecruitingMikhail Kirov, MD
Astrakhan State Medical University
Astrakhan, Russia
RecruitingIrakli Kitiashvili, MD
Irakli Kitiashvili, MD
Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
Chelyabinsk, Russia
RecruitingDmitry Voroshin, MD
South-Ural State Medical University
Chelyabinsk, Russia
RecruitingAlexey Astakhov, MD · aaastakhov@gmail.com
Alexey Astakhov, MD
Chita state medical Academy of the Ministry of health of the Russian Federation
Chita, Russia
RecruitingKonstantin Shapovalov, MD · shkg26@mail.ru
Konstantin Shapovalov, MD
Kazan State Medical University
Kazan', Russia
RecruitingVeronika Davydova, PhD · vevojuyar@gmail.com
Veronika Davydova, PhD
Republic Clinical Hospital Ministry of Health care of the Republic of Tatarstan
Kazan', Russia
RecruitingAinagul Bayalieva, MD · bayalieva1@yandex.ru
Ainagul Bayalieva, MD
Research Institute for Complex Issues of Cardiovascular Diseases
Kemerovo, Russia
RecruitingYevgeny Grigoriev, MD · grigorievev@hotmail.com
Yevgeny Grigoriev, MD
Regional clinical hospital №2
Krasnodar, Russia
RecruitingNikita Trembach, PhD · nikitkax@mail.ru
Nikita Trembach, PhD
Kuban State Medical University
Krasnodar, Russia
RecruitingIgor Zabolotskikh · pobeda_zib@mail.ru
Igor Zabolotskikh, MD
Research Institute Regional Clinical Hospital named after S.V. Ochapovsky
Krasnodar, Russia
RecruitingYuri Malyshev, MD · malyshevyp@mail.ru
Yuri Malyshev, MD
Krasnoyarsk State Medical University named after Prof. V.F.Voino-Yasenetsky
Krasnoyarsk, Russia
RecruitingAlexey Gritsan, MD · gritsan67@mail.ru
Alexey Gritsan, MD
Burnasyan federal medical biophysical center of federal medical biological agency
Moscow, Russia
RecruitingSergey Voskanyan, MD · voskanyan_se@mail.ru
Sergey Voskanyan, MD
City clinical hospital named after S.S. Yudin
Moscow, Russia
RecruitingDenis Protsenko, PhD · drprotsenko@me.com
Denis Protsenko, PhD
City clinical hospital №1 named after N.I. Pirogov
Moscow, Russia
RecruitingMarat Magomedov, PhD · mma16@bk.ru
Marat Magomedov, PhD
City Clinical Hospital. n.a. F.I. Inozemtseva
Moscow, Russia
RecruitingNina Arikan
FGBU "Central clinical hospital with polyclinic" of the President administration of the Russian Federation
Moscow, Russia
RecruitingRinat Gubaidullin, MD · www.tempcor@list.ru
Rinat Gubaidullin, MD
Moscow cancer research Institute named after P. A. Herzen
Moscow, Russia
RecruitingVictoria Khoronenko, MD · khoronenko_mnioi@mail.ru
Victoria Khoronenko, MD
Moscow City Oncological Hospital № 62
Moscow, Russia
RecruitingAndrey Khoteev, PhD · a_hoteev@mail.ru
Moscow regional research clinical Institute named after M. F. Vladimirsky
Moscow, Russia
RecruitingAlexey Ovezov, MD · amolex@mail.ru
Alexey Ovezov, MD
National Medical and Surgical Center named after N.I. Pirogov
Moscow, Russia
RecruitingMikhail Zamyatin, MD · zamyatinmn@pirogov-center.ru
Mikhail Zamyatin, MD
Privolzhsky district medical center
Nizhny Novgorod, Russia
RecruitingVladislav Belsky · vlad.belsky@gmail.com
Vladislav Belsky
State Novosibirsk Regional Clinical Hospital
Novosibirsk, Russia
RecruitingVladimir Kohno, MD · kair2007@mail.ru
Vladimir Kohno, MD
Orenburg Regional Clinical Hospital
Orenburg, Russia
RecruitingVadim Ershov, MD · ervad2010@yandex.ru
Vadim Ershov, MD
"Republican hospital named after V. A. Baranov"
Petrozavodsk, Russia
RecruitingArina Spasova, PhD · arina22@mail.ru
Arina Spasova, PhD
Rostov State Medical University
Rostov-on-Don, Russia
RecruitingDmitry Martynov, PhD · dvmartyn@mail.ru
Dmitry Martynov, PhD
North-West State Medical University named after I.I.Mechnikov
Saint Petersburg, Russia
RecruitingKonstantin Lebedinski, MD · mail@lebedinski.com
Konstantin Lebedinski, MD
St. Petersburg state budgetary healthcare institution " City clinical Oncology dispensary"
Saint Petersburg, Russia
RecruitingAzam Khalikov, PhD · jawlan2@gmail.com
Azam Khalikov, PhD
"Samara Regional Clinical Oncology Dispensary"
Samara, Russia
RecruitingVladimir Stadler, PhD · ev.stadler@mail.ru
Vladimir Stadler, PhD
Clinical Hospital named after SR. Mirotvortseva (FGBOU VO "Saratov State Medical University. n.a. V.I.Razumovsky" Ministry of Health of the Russian Federation
Saratov, Russia
RecruitingMikhail Prigorodov, MD
Mikhail Prigorodov, MD
Stavropol regional clinical hospital
Stavropol, Russia
RecruitingVasily Fisher, PhD · vvfisher26@gmail.com
Vasily Fisher, PhD
Regional Clinical Hospital No. 1
Tyumen, Russia
Not yet recruitingNatalya Schen
Regional clinical hospital №2
Vladivostok, Russia
RecruitingPavel Dunts, PhD · dpv@bk.ru
Pavel Dunts, PhD
Emergency hospital
Volgograd, Russia
RecruitingAlexandr Popov, MD · airvma@yandex.ru
Alexandr Popov, MD
Volgograd regional clinical hospital
Volgograd, Russia
RecruitingAlexandr Popov, MD · airvma@yandex.ru
Alexandr Popov, MD
Yakut Republican Oncological Dispensary
Yakutsk, Russia
RecruitingAfanasiy Matveev, MD
Ekaterinburg City clinical hospital № 40
Yekaterinburg, Russia
RecruitingVladimir Rudnov, MD · vrudnov@mail.ru
Vladimir Rudnov, MD
Sverdlovsk regional clinicl hospital №1
Yekaterinburg, Russia
RecruitingDmitry Levit, PhD · d78@inbox.ru
Dmitry Levit, PhD
The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.